Gissette Soffer, MD

Profile Headshot

Overview

Academic Appointments

  • Assistant Professor of Medicine at CUMC

Despite an unconventional path to become a clinical-translational researcher, I have been able to develop and demonstrate expertise and leadership in the execution of clinical research projects. My academic achievements could not be possible without the exceptional guidance, friendship and mentorship of Dr. Henry N. Ginsberg. I am highly motivated, enthusiastic, persistent, and extremely goal oriented. I obtained an MD from the Pontificia Universidad Catolica Madre y Maestra, Santiago, Dominican Republic, my homeland. I completed my post graduate work at Columbia University Medical Center (CUMC), sponsored by an NIH T32- Atherosclerosis training grant. In 2007, I joined the faculty of the Dept of Medicine, Division of Preventive Medicine and Nutrition at CUMC. I am currently an Assistant Professor of Medicine at CUIMC. My laboratory focuses on understanding the mechanisms that regulate lipid and lipoproteins in health and disease states. The laboratory has independent funding from NIH-NHLBI and internal career development grants. We have received funding from Industry to study the mechanisms regulating lipid and lipoproteins following treatments with novel lipid lowering therapies. We have a growing list of publications and many future projects in the pipeline.  

Languages

  • Spanish

Gender

  • Female

Credentials & Experience

Education & Training

  • MD, Medicine , Pontifical Catholic University Madre and Maestra (Dominican Republic)
  • Internship: Pontifical Catholic University Madre and Maestra (Dominican Republic)
  • Fellowship: Columbia University College of Physicians and Surgeons

Honors & Awards

Herbert Irving Professor of Medicine (2019-2023). 

Research

Grants

PHENOTYPING GENETIC DISORDERS OF HEPATIC LIPID AND LIPOPROTEIN METABOLISM IN CELLS, MICE, AND MEN (Federal Gov)

Jan 1 2017 - Dec 31 2023

UNRAVELING THE COMPLEXITY OF LIPOPROTEIN(A) METABOLISM: HUMAN KINETIC STUDIE (Federal Gov)

Aug 1 2018 - May 31 2022

INSTITUTIONAL CAREER DEVELOPMENT CORE (Federal Gov)

Jul 1 2016 - May 31 2021

AN OFF-DRUG FOLLOW-UP STUDY OF WOMEN OF CHILD-BEARING POTENTIAL AND OFF-DRUG FOLLOW-UP PHARMACOKINETIC STUDY OF MEN AND WOMEN WHO PREVIOUSLY RECEIVED MULTIPLE ORAL DOSES OF MK-0859 (P&S Industry Clinical Trial)

Mar 31 2014 - Mar 31 2019

A PHASE 1 STUDY OF THE EFFECTS OF SUBCUTANEOUS DOSES OF ALIROCUMAB ON LIPID AND (P&S Industry Clinical Trial)

Nov 18 2013 - Nov 18 2018

CLINICAL AND TRANSLATIONAL SCIENCE AWARD (Federal Gov)

Sep 30 2006 - Jun 30 2016

PATHWAYS OF FENOFIBRATE EFFECTS ON CARDIOVASCULAR OUTCOMES IN ACCORD (Federal Gov)

Apr 1 2012 - Mar 31 2016